Literature DB >> 10319410

Immunosuppressive effects of the heat shock protein 90-binding antibiotic geldanamycin.

T Sugita1, S Tanaka, T Murakami, H Miyoshi, T Ohnuki.   

Abstract

Ansamycin antibiotic, geldanamycin has a unique pharmacological effect to bind to heat shock protein 90 (hsp90) and deplete hsp90 substrates. We investigated the immunopharmacological effects of geldanamycin. Geldanamycin depleted cellular Raf-1 of rat splenic cells without affecting the steady state levels of hsp90 and downstream mitogen activated protein (MAP) kinases, ERK1 and ERK2. In parallel, it inhibited mitogen-induced nuclear factor-kappa B (NF-kappa B) activation in these cells. Geldanamycin also had a potent suppressive effect on recall antigen-induced T cell proliferation, with an IC50 value of 1 nM. In vivo, geldanamycin suppressed the progression of adjuvant-induced arthritis dose-dependently. These results suggest that geldanamycin exerts an immunosuppressive effect partly through destabilizing Raf-1, and raise a new strategy for the prevention of inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10319410     DOI: 10.1080/15216549900201633

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  6 in total

1.  The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation.

Authors:  T Schnaider; J Somogyi; P Csermely; M Szamel
Journal:  Cell Stress Chaperones       Date:  2000-01       Impact factor: 3.667

2.  Role of the heat shock protein 90 in immune response stimulation by bacterial DNA and synthetic oligonucleotides.

Authors:  F G Zhu; D S Pisetsky
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

Review 3.  The involvement of heat-shock proteins in the pathogenesis of autoimmune arthritis: a critical appraisal.

Authors:  Min-Nung Huang; Hua Yu; Kamal D Moudgil
Journal:  Semin Arthritis Rheum       Date:  2009-12-06       Impact factor: 5.532

4.  The anticancer drug AUY922 generates a proteomics fingerprint that is highly conserved among structurally diverse Hsp90 inhibitors.

Authors:  Sudhakar Voruganti; Jeff C Lacroix; Chelsea N Rogers; Janet Rogers; Robert L Matts; Steven D Hartson
Journal:  J Proteome Res       Date:  2013-06-27       Impact factor: 4.466

5.  Gambogic acid is cytotoxic to cancer cells through inhibition of the ubiquitin-proteasome system.

Authors:  Jenny Felth; Karolina Lesiak-Mieczkowska; Padraig D'Arcy; Caroline Haglund; Joachim Gullbo; Rolf Larsson; Stig Linder; Lars Bohlin; Mårten Fryknäs; Linda Rickardson
Journal:  Invest New Drugs       Date:  2012-11-20       Impact factor: 3.850

Review 6.  Therapeutic and diagnostic implications of Hsp90 activation.

Authors:  Adeela Kamal; Marcus F Boehm; Francis J Burrows
Journal:  Trends Mol Med       Date:  2004-06       Impact factor: 11.951

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.